Literature DB >> 25855378

Vimentin-ERK Signaling Uncouples Slug Gene Regulatory Function.

Reetta Virtakoivu1, Anja Mai2, Elina Mattila1, Nicola De Franceschi1, Susumu Y Imanishi2, Garry Corthals2, Riina Kaukonen1, Markku Saari1, Fang Cheng3, Elin Torvaldson3, Veli-Matti Kosma4, Arto Mannermaa4, Ghaffar Muharram1, Christine Gilles5, John Eriksson6, Ylermi Soini4, James B Lorens7, Johanna Ivaska8.   

Abstract

Epithelial-mesenchymal transition (EMT) in cells is a developmental process adopted during tumorigenesis that promotes metastatic capacity. In this study, we advance understanding of EMT control in cancer cells with the description of a novel vimentin-ERK axis that regulates the transcriptional activity of Slug (SNAI2). Vimentin, ERK, and Slug exhibited overlapping subcellular localization in clinical specimens of triple-negative breast carcinoma. RNAi-mediated ablation of these gene products inhibited cancer cell migration and cell invasion through a laminin-rich matrix. Biochemical analyses demonstrated direct interaction of vimentin and ERK, which promoted ERK activation and enhanced vimentin transcription. Consistent with its role as an intermediate filament, vimentin acted as a scaffold to recruit Slug to ERK and promote Slug phosphorylation at serine-87. Site-directed mutagenesis established a requirement for ERK-mediated Slug phosphorylation in EMT initiation. Together, these findings identified a pivotal step in controlling the ability of Slug to organize hallmarks of EMT. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25855378     DOI: 10.1158/0008-5472.CAN-14-2842

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  56 in total

1.  A vimentin binding small molecule leads to mitotic disruption in mesenchymal cancers.

Authors:  Michael J Bollong; Mika Pietilä; Aaron D Pearson; Tapasree Roy Sarkar; Insha Ahmad; Rama Soundararajan; Costas A Lyssiotis; Sendurai A Mani; Peter G Schultz; Luke L Lairson
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-30       Impact factor: 11.205

2.  The p21-activated kinase 4-Slug transcription factor axis promotes epithelial-mesenchymal transition and worsens prognosis in prostate cancer.

Authors:  Jung-Jin Park; Mee-Hee Park; Eun Hye Oh; Nak-Kyun Soung; Soo Jae Lee; Jae-Kyung Jung; Ok-Jun Lee; Seok Joong Yun; Wun-Jae Kim; Eun-Young Shin; Eung-Gook Kim
Journal:  Oncogene       Date:  2018-05-30       Impact factor: 9.867

3.  Mesenchymal and MAPK Expression Signatures Associate with Telomerase Promoter Mutations in Multiple Cancers.

Authors:  Pablo Tamayo; Thomas R Cech; Franklin W Huang; Josh Lewis Stern; Grace Hibshman; Kevin Hu; Sarah E Ferrara; James C Costello; William Kim
Journal:  Mol Cancer Res       Date:  2020-04-10       Impact factor: 5.852

Review 4.  Intermediate Filaments and the Regulation of Cell Motility during Regeneration and Wound Healing.

Authors:  Fang Cheng; John E Eriksson
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-09-01       Impact factor: 10.005

5.  Selective regulation of Notch ligands during angiogenesis is mediated by vimentin.

Authors:  Daniel Antfolk; Marika Sjöqvist; Fang Cheng; Kimmo Isoniemi; Camille L Duran; Adolfo Rivero-Muller; Christian Antila; Rasmus Niemi; Sebastian Landor; Carlijn V C Bouten; Kayla J Bayless; John E Eriksson; Cecilia M Sahlgren
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-22       Impact factor: 11.205

6.  Sustained activation of ERK1/2 MAPK in Schwann cells causes corneal neurofibroma.

Authors:  Paola Bargagna-Mohan; Akihiro Ishii; Ling Lei; Daniel Sheehy; Saagar Pandit; Grace Chan; Rashmi Bansal; Royce Mohan
Journal:  J Neurosci Res       Date:  2017-05-10       Impact factor: 4.164

7.  Interstitial fluid pressure regulates collective invasion in engineered human breast tumors via Snail, vimentin, and E-cadherin.

Authors:  Alexandra S Piotrowski-Daspit; Joe Tien; Celeste M Nelson
Journal:  Integr Biol (Camb)       Date:  2016-03-14       Impact factor: 2.192

8.  Vimentin Promotes Astrocyte Activation After Chronic Constriction Injury.

Authors:  Pengfei Xue; Liming Chen; Xiongsong Lu; Jinlong Zhang; Guofeng Bao; Guanhua Xu; Yuyu Sun; Xiaofeng Guo; Jiawei Jiang; Haiyan Gu; Zhiming Cui
Journal:  J Mol Neurosci       Date:  2017-08-08       Impact factor: 3.444

9.  Vimentin coordinates fibroblast proliferation and keratinocyte differentiation in wound healing via TGF-β-Slug signaling.

Authors:  Fang Cheng; Yue Shen; Ponnuswamy Mohanasundaram; Michelle Lindström; Johanna Ivaska; Tor Ny; John E Eriksson
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-08       Impact factor: 11.205

10.  Novel anti-cancer agent myrtucommulone-A and thymoquinone abrogate epithelial-mesenchymal transition in cancer cells mainly through the inhibition of PI3K/AKT signalling axis.

Authors:  Banu Iskender; Kenan Izgi; Halit Canatan
Journal:  Mol Cell Biochem       Date:  2016-03-31       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.